4 резултати
FIELD OF THE INVENTION
The present invention relates to certain aryl-substituted bridged or fused diamine compounds, pharmaceutical compositions containing them, and methods of using the compounds and pharmaceutical compositions for leukotriene A.sub.4 hydrolase (LTA.sub.4H or LTA4H) modulation and
FIELD OF THE INVENTION
The present invention relates to certain aryl-substituted bridged or fused diamine compounds, pharmaceutical compositions containing them, and methods of using the compounds and pharmaceutical compositions for leukotriene A.sub.4 hydrolase (LTA.sub.4H or LTA4H) modulation and
FIELD OF THE INVENTION
This invention relates to compounds that inhibit nitochondrial F.sub.1 F.sub.0 ATP hydrolase and are useful for treating ischemia-related diseases. The invention further pertains to methods of treating conditions associated with depleted levels of adenosine triphosphate (ATP)
FIELD OF THE INVENTION
The present invention relates to certain aryl-substituted bridged or fused diamine compounds, pharmaceutical compositions containing them, and methods of using the compounds and pharmaceutical compositions for leukotriene A.sub.4 hydrolase (LTA.sub.4H or LTA4H) modulation and